Table 1.
Characteristics of clinical trials on ADSCs in SCI found on clinicaltrials.gov.
| NCT Number | Study Title | Study Status | Results | Sex | Enrollment | Phase | Start Date | Duration | Location |
|---|---|---|---|---|---|---|---|---|---|
| NCT02981576 | Safety and Effectiveness of BM-MSC vs. AT-MSC in the Treatment of SCI Patients. | Completed | No | All | 14 | I/II | November 2016 | 3 years | Jordan |
| NCT02917291 | Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury. | Unknown | No | All | 48 | I/II | December 2016 | 7 years | Spain |
| NCT02034669 | Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment. | Unknown | No | All | 48 | I/II | February 2013 | 2 years | Vietnam |
| NCT01769872 | Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury. | Completed | No | All | 15 | I/II | January 2013 | 3 years | Republic of Korea |
| NCT01624779 | Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury. | Completed | Yes | All | 15 | I | April 2012 | 2 years | Republic of Korea |
| NCT01274975 | Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury. | Completed | Yes | Male | 8 | I | July 2009 | 1 year | Republic of Korea |
| NCT05018793 | Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intrathecal Injection for SCI. | Suspended | No | All | 15 | I | December 2012 | 4 years | Greece |
| NCT04520373 | Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients. | Recruiting | No | All | 40 | II | June 2020 | 4 years | United States |
| NCT04064957 | Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Spinal Cord Injury. | No longer available | No | All | N/A | N/A | N/A | N/A | United States |
| NCT03925649 | Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI. | No longer available | No | Male | N/A | N/A | N/A | N/A | United States |
| NCT03308565 | Adipose Stem Cells for Traumatic Spinal Cord Injury. | Completed | Yes | All | 10 | I | December 2017 | 4 years | United States |